[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cough, Cold and Allergy (Hay Fever) Remedies in South Africa

February 2020 | 22 pages | ID: C56F516D583EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Cough, cold and allergy (hay fever) remedies continues to record double-digit current value growth in 2019. Sales growth continues to be fuelled by increasing self-medication. Ongoing economic uncertainty has resulted in high unemployment, falling disposable income levels per capita and job insecurity. This has made it harder for many people to take time off work to go to the doctor, with it also cheaper for consumers to buy OTC products to alleviate the symptoms of coughs, colds and flu.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in South Africa report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Economic Uncertainty Benefits Sales, With Many Reluctant To Take Time Off Work
Antihistamines/allergy Remedies (systemic) Benefit From Rising Pollution and Global Warming
Cough Remedies See Strong Growth Despite Addiction Concerns But Legislation May Tighten Further
Competitive Landscape
Adcock Ingram Remains Strong Leader, Benefiting From Strength of Allergex
Procter & Gamble Turns Back on Pgt and Looks To Merck
Gsk Consumer Healthcare Created by GlaxoSmithKline and Pfizer Merger
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2014-2019
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2019
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2019
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Executive Summary
Economic Uncertainty and Increasing Internet Use Encourage Self-medication
Declining Disposable Income Levels Result in Higher Price-sensitivity
Adcock Ingram Maintains Lead While Gsk Leaps To Second Place
Drugstores/parapharmacies Benefit From Offering Value for Money
Slower Growth Ahead Due To Ongoing Price-sensitivity
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019
Market Data
Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches 2018-2019
Definitions
Sources
Summary 2 Research Sources


More Publications